The global insulin pumps market is a mature market in the current scenario, in developed countries as well as in developing economies worldwide. Over the past few years, products with increased technology with more effective benefits is a major requirement in the treatment for diabetes. The advancement and development in treatment is increasing in the last few years. As the prevalence of diabetes is increasing across the world, the demand for more products with advancements is also boosting up. Hence, over the years, researchers have been carrying out research activities that have resulted to product innovations.
Get a Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPHE100001290/
The global insulin pumps market was valued at US$ 3,822.44 Mn in 2017 and is estimated to reach US$ 8,264.01 Mn by 2025. The report highlights the trends prevalent in the global insulin pumps market and the factors driving the market along with those that act as deterrents to its growth.
Top Players Synopsis-
- Insulet Corporation
- Tandem Diabetes Care, Inc
- Debiotech S.A
- SOOIL Developments Co., Ltd
- MicroPort Scientific Corporation
- Valeritas Inc.
- Hoffmann-La Roche Ltd.
- Ypsomed AG
The pumps market is holding the largest share in the current market arena, by the product segment. The pumps are mimic the function of a normal pancreas that delivering a basal insulin dose, and bolus doses at mealtime, when blood glucose (sugar) levels is increased above than normal rate. These are portable devices that are used in the diabetes management for the administering of continues fast acting insulin in the body. The insulin pumps typically hold between 176 and 300 units of insulin. Thus, the increasing demand for insulin pumps is expected to help the insulin pumps market to grow.
Speak to Analyst at https://www.theinsightpartners.com/speak-to-analyst/TIPHE100001290
The increasing product development with advanced technology is expected to provide impetus for the growth of the insulin pumps market during the forecast period. For instance, the Guardian Connect system, by Medtronic, developed the advanced feature including alert system that helps in aware people about potential high or low glucose level events, up to 60 minutes in advance. The system is proven in a clinical study to accurately alert patients of 98.5 % of hypoglycemic events. Moreover, the Accu-Chek Solo micropump system by Roche comprise detach and re-attach function of pump without wasting insulin.
Type II diabetes is also contribute the significant role in increasing the growth of the Insulin Pumps Market. Type II diabetes is a condition in which body does a poor job and turning the carbohydrates in food into energy that cause sugar (glucose) to build up in the blood. In turns, the risk upsurge to get heart disease, blindness, nerve and organ damage, and other serious conditions. According to the Centers for Disease Control and Prevention (CDC), approximately 14%, or 3.2 million people estimated to manage their diabetes with insulin only in the United States. Insulin pumps are used to for curing the people with type II diabetes that help in makes insulin to control the blood sugar levels
The global Insulin Pumps Market by type was led by tube pumps segment. In 2017, the pumps segment held a largest market share of 85.7% of the insulin pumps market, by type. The segment is also expected to dominate the market in 2025, since pump helps in delivering precise amount of insulin to the body than any other insulin delivery devices.
The global insulin pumps market by product was led by pumps segment. In 2017, the pumps segment held a largest market share of 76.8% of the insulin pumps market, by product. The segment is also expected to dominate the market in 2025, since they offer are used in the diabetes management for the administering of continues fast acting insulin in the body.
The insulin pumps market by application was segmented into type I diabetes and type II diabetes. The type I diabetes segment held the largest share of the market, by application. The segment is also likely to dominate during the forecast period, due to increase in the cases of type I diabetes among individuals, mostly in the developed nations.
Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPHE100001290/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi